Clinical Trial Update: Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating megestrol to limit weight loss and improve quality of life in patients with head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anorexia
• Cachexia
• Head and Neck Cancer

Drugs mentioned

• megestrol (megestrol)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Anorexia, Cachexia | Phase 3 | Status: COMPLETED